Heterogeneity of colorectal cancer risk by tumour characteristics: Large prospective study of UK women

International Journal of Cancer

Volumn 140, Issue 5, 2017, Pages 1082-1090

  Burón Pust, Andrea ^a,b,c,d   Alison, Rupert ^a   Blanks, Roger ^a   Pirie, Kirstin ^a   Gaitskell, Kezia ^a   Barnes, Isobel ^a   Gathani, Toral ^a   Reeves, Gillian ^a   Beral, Valerie ^a   Green, Jane ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b Hospital del Ma   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d Red de Investigación en Servicios de Salud de Enfermedades Crónicas   (Spain)

Author keywords

colorectal cancer; risk factors; smoking; subtype

Indexed keywords

ADENOCARCINOMA; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY HEIGHT; BODY MASS; CANCER RISK; COHORT ANALYSIS; COLON TUMOR; COLORECTAL CANCER; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; NEUROENDOCRINE TUMOR; NULLIPARA; OBESITY; PARITY; PHYSICAL ACTIVITY; PROSPECTIVE STUDY; RECTUM TUMOR; SIGNET RING CARCINOMA; SMOKING; UNITED KINGDOM; ADVERSE EFFECTS; ANTIBODY SPECIFICITY; CARCINOMA; CLASSIFICATION; COLORECTAL NEOPLASMS; DRINKING BEHAVIOR; EXERCISE; FOLLOW UP; MENOPAUSE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; QUESTIONNAIRE; REPRODUCTIVE HISTORY; RISK;

ORAL CONTRACEPTIVE AGENT;

ADENOCARCINOMA; ALCOHOL DRINKING; CARCINOMA; COLORECTAL NEOPLASMS; CONTRACEPTIVES, ORAL, HORMONAL; EXERCISE; FEMALE; FOLLOW-UP STUDIES; HORMONE REPLACEMENT THERAPY; HUMANS; MENOPAUSE; MIDDLE AGED; NEUROENDOCRINE TUMORS; OBESITY; ORGAN SPECIFICITY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REPRODUCTIVE HISTORY; RISK; SMOKING; SURVEYS AND QUESTIONNAIRES; UNITED KINGDOM;

EID: 85010424049     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.30527     Document Type: Article

References (27)

1. Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet 2014; 383:1490–502. doi: 10.1016/S0140-6736(13)61649-9.
2. IJspeert JE, Vermeulen L, Meijer GA, et al. Serrated neoplasia-role in colorectal carcinogenesis and clinical implications. Nat Rev Gastroenterol Hepatol 2015; 12:401–9. doi: 10.1038/nrgastro.2015.73.
3. Guinney J, Dienstmann R, Wang X, et al. The consensus molecular subtypes of colorectal cancer. Nat Med 2015; 21:1350–6. doi: 10.1038/nm.3967.
4. Kocarnik JM, Shiovitz S, Phipps AI. Molecular phenotypes of colorectal cancer and potential clinical applications. Gastroenterol Rep (Oxf) 2015; 3:269–76. doi: 10.1093/gastro/gov046.
5. Million Women Study Collaborative Group. The Million Women Study: design and characteristics of the study population. Breast Cancer Res 1999; 1:73–80.
6. Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003; 362:419–27.
7. World Health Organization. International Statistical Classification of Diseases and related health problems, 10th revision. Geneva: World Health Organization, 1992.
8. Percy C, Van Holten V, Muir CS. International Classification of Diseases for Oncology: ICD-O, 2nd edn. Geneva: World Health Organization, 1990.
9. Fritz A, Percy C, Jack. International Classification of Diseases for Oncology: ICD-O, 3rd edn. Geneva: World Health Organization, 2000
10. Bosman FT, Carneiro F, Hruban RH, Theise ND, eds. WHO Classification of Tumours of the Digestive System. Lyon: IARC, 2010.
11. Townsend P, Phillimore P, Beattie A. Health and Deprivation: inequality and the North. London: Croon Helm, 1988.
12. Blanks RG, Benson VS, Alison R, et al. Nationwide bowel cancer screening programme in England: cohort study of lifestyle factors affecting participation and outcomes in women. Br J Cancer 2015; 112:1562–7.
13. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979; 6:65–70.
14. StataCorp. Stata statistical software: release 14. College Station, TX: StataCorp LP, 2015.
15. Monographs on the evaluation of carcinogenic risks to humans, Vol. 100E. A review of human carcinogens. Part E: Personal habits and indoor combustions. Lyon, France: IARC, 2012.
16. WCRF/AICR. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: World Cancer Research Fund/American Institute of Cancer Research, 2007.
17. http://www.wcrf.org/int/research-we-fund/continuous-update-project-findings-reports/colorectal-bowel-cancer. Last accessed August 22, 2016.
18. Iacopetta B. Are there two sides to colorectal cancer? Int J Cancer 2002; 101:403–8.
19. Yamauchi M, Lochhead P, Morikawa T, et al. Colorectal cancer: a tale of two sides or a continuum? Gut 2012; 61:794–7. doi:10.1136/gutjnl-2012-302014.
20. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 2007; 50:113–30.
21. Limsui D, Vierkant RA, Tillmans LS, et al. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst 2010; 102:1012–22. doi: 10.1093/jnci/djq201.
22. Nishihara R, Morikawa T, Kuchiba A, et al. A prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics-related tumor classification. Am J Epidemiol 2013; 178:84–100. doi: 10.1093/aje/kws431.
23. Weisenberger DJ, Levine AJ, Long TI, for the Colon Cancer Family Registry, et al. Association of the colorectal CpG island methylator phenotype with molecular features, risk factors, and family history. Cancer Epidemiol Biomarkers Prev 2015; 24:512–19. doi: 10.1158/1055-9965.EPI-14-1161.
24. Slattery ML, Curtin K, Anderson K, et al. Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst 2000; 92:1831–6.
25. Samowitz WS, Albertsen H, Sweeney C, et al. Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer. J Natl Cancer Inst 2006; 98:1731–8.
26. Figueiredo JC, Crockett SD, Snover DC, et al. Smoking-associated risks of conventional adenomas and serrated polyps in the colorectum. Cancer Causes Control 2015; 26:377–86. doi: 10.1007/s10552-014-0513-0.
27. IJspeert JE, Bossuyt PM, Kuipers EJ, et al. Smoking status informs about the risk of advanced serrated polyps in a screening population. Endosc Int Open 2016; 4:E73–8. doi: 10.1055/s-0034-1393361.